Activation of PPARγ attenuates LPS-induced acute lung injury by inhibition of HMGB1-RAGE levels-Reference-Cited by-全球学者库

Activation of PPARγ attenuates LPS-induced acute lung injury by inhibition of HMGB1-RAGE levels

Published:2014-03 Issue: Volume:726 Page:27-32
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Wang Guizuo,Liu Lu,Zhang Yonghong,Han Dong,Lu Jiamei,Xu Jing,Xie Xinming,Wu Yuanyuan,Zhang Dexin,Ke Rui,Li Shaojun,Zhu Yanting,Feng Wei,Li Manxiang

Publisher

Elsevier BV

Subject

Pharmacology

Reference38 articles.

1. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis;Angus;Crit. Care Med.,2007

2. Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis;Aoki;Respir.; Int. Rev. Thorac. Dis.,2009

3. Peroxisome proliferator-activated receptors as novel targets in lung disease;Belvisi;Chest,2008

4. The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?;Creagh-Brown;Intensive Care Med.,2010

5. Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury;Cross;Crit. Care Clin.,2011

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of biomarkers and molecular signaling pathways in acute lung injury;Fundamental & Clinical Pharmacology;2024-01-26

2. The HMGB1-RAGE axis induces apoptosis in acute respiratory distress syndrome through PERK/eIF2α/ATF4-mediated endoplasmic reticulum stress;Inflammation Research;2022-07-24

3. Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review;Biomedicine & Pharmacotherapy;2022-07

4. Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function;Drug Design, Development and Therapy;2022-06

5. Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment—From Mice to Men;Biomedicines;2022-01-04